ArchivesJohn Walker2023-02-27T20:11:47-08:00

Archives

108, 2023

Prometheus Laboratories Announces Collaboration with Fresenius Kabi on Anser® Testing

John Walker2024-03-13T11:46:12-07:002023-08-01|

News & Events Prometheus [...]

2707, 2023

Prometheus Laboratories Announces the Launch of PredictrPK® ADA, A Precision-Guided Dosing Test for Optimization of Adalimumab

John Walker2023-07-26T15:59:06-07:002023-07-27|

News & Events Prometheus [...]

205, 2023

Lynx.MD Partners with Prometheus Laboratories and Gastro Health to Leverage Medical Data Intelligence Platform for Inflammatory Bowel Disease Research

John Walker2023-07-18T16:09:33-07:002023-05-02|

News & Events Lynx.MD [...]

203, 2023

Prometheus Launches New Indication for PredictrPK® IFX, A Precision-Guided Dosing Test for IBD

John Walker2023-04-12T22:31:38-07:002023-03-02|

News & Events [...]

1409, 2022

Prometheus Laboratories Announces Partnership with Takeda to Launch CDPATH™, a Personalized Prognostic Tool Advancing Innovation for Crohn’s Disease Patients

Judy Gohndrone2022-09-14T16:21:35-07:002022-09-14|

News & Events [...]

2202, 2022

Prometheus Laboratories Announces the Launch of PredictrPK® IFX, A Revolutionary Test Enabling Precision-Guided Dosing for Inflammatory Bowel Disease

John Walker2023-03-26T22:10:02-07:002022-02-22|

News & Events [...]

Previous 234 Next